13-cis-retinoic acid,Isotretinoin

13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.

Cross Reference

Introduction

To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 13-cis-retinoic acid,Isotretinoin?

13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin

MeSH term MeSH ID Detail
Lung Neoplasms D008175 171 associated lipids
Acne Vulgaris D000152 35 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with 13-cis-retinoic acid,Isotretinoin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 13-cis-retinoic acid,Isotretinoin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

What genes are associated with 13-cis-retinoic acid,Isotretinoin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 13-cis-retinoic acid,Isotretinoin

Download all related citations
Per page 10 20 50 100 | Total 2952
Authors Title Published Journal PubMed Link
Kartal D et al. Effects of isotretinoin on the olfactory function in patients with acne. 2017 Mar-Apr An Bras Dermatol pmid:28538877
Ardeshna KP et al. Author's reply. 2017 Jan-Feb Indian J Dermatol Venereol Leprol pmid:27917843
Srivastava A and Kothiwala SK Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis? 2017 Jan-Feb Indian J Dermatol Venereol Leprol pmid:27853005
Maor D and Chong AH Rosacea. 2017 Aust Fam Physician pmid:28472572
Reigada C et al. Trypanocidal Effect of Isotretinoin through the Inhibition of Polyamine and Amino Acid Transporters in Trypanosoma cruzi. 2017 PLoS Negl Trop Dis pmid:28306713
Melnik BC Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity. 2017 Acta Derm. Venereol. pmid:27671426
Sameem F and Semira Isotretinoin-induced acute severe myopathy involving pelvic girdle muscles: A case report. 2016 Sep-Oct Indian J Pharmacol pmid:27721552
Ardeshna KP et al. Successful treatment of recurrent dermatophytosis with isotretinoin and itraconazole. 2016 Sep-Oct Indian J Dermatol Venereol Leprol pmid:27297276
Uyar B et al. Effects of isotretinoin on the thyroid gland and thyroid function tests in acne patients: A preliminary study. 2016 Sep-Oct Indian J Dermatol Venereol Leprol pmid:27212279
Alan S et al. Premature ventricular contractions associated with isotretinoin use. 2016 Nov-Dec An Bras Dermatol pmid:28099609
Wang W et al. Premature sebaceous hyperplasia with satisfactory response to oral isotretinoin. 2016 Jan-Feb Indian J Dermatol Venereol Leprol pmid:26728839
Czilli T et al. Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines. 2016 J Cutan Med Surg pmid:27281440
Zhao X et al. Prolonged Inner Retinal Photoreception Depends on the Visual Retinoid Cycle. 2016 J. Neurosci. pmid:27076420
Leyden J Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne. 2016 J Dermatolog Treat pmid:26947815
Tintle SJ et al. Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri. 2016 JAMA Dermatol pmid:26580859
Aslan Bayhan S et al. Effects of topical acne treatment on the ocular surface in patients with acne vulgaris. 2016 Cont Lens Anterior Eye pmid:27422575
Asai Y et al. Canadian Clinical Practice Guidelines for Rosacea. 2016 J Cutan Med Surg pmid:27207355
Yeo PM et al. Paradoxical Worsening of Truncal Acne with Doxycycline. 2016 Ann. Acad. Med. Singap. pmid:27748793
Szychot E et al. Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma. 2016 Postepy Hig Med Dosw (Online) pmid:27708204
Schaller M and Gonser L A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report. 2016 Drugs R D pmid:27623792
Wu H et al. Developmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 Mice. 2016 PLoS ONE pmid:27606422
Wilson RD A preventable teratology: isotretinoin. 2016 CMAJ pmid:27601629
Hitzeman N Family Physicians Are Well-Suited to Prescribe Isotretinoin. 2016 Am Fam Physician pmid:27583417
Brar G et al. Is less more with isotretinoin and acne? 2016 Can Fam Physician pmid:27255624
Dressler C et al. How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy. 2016 Dermatology (Basel) pmid:27220773
van Zuuren EJ and Fedorowicz Z Low-Dose Isotretinoin: An Option for Difficult-to-Treat Papulopustular Rosacea. 2016 J. Invest. Dermatol. pmid:27212646
Figueiras Dde A et al. Paronychia and granulation tissue formation during treatment with isotretinoin. 2016 An Bras Dermatol pmid:27192525
Bari O and Paravar T Isotretinoin therapy for the treatment of acne in patients with cystic fibrosis: a case series and review of the literature. 2016 Dermatol. Online J. pmid:27136632
Henry D et al. Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy. 2016 CMAJ pmid:27114489
Xing F et al. Effect of retinoic acid on aquaporin 3 expression in keratinocytes. 2016 Genet. Mol. Res. pmid:26985947
Zaenglein AL et al. Guidelines of care for the management of acne vulgaris. 2016 J. Am. Acad. Dermatol. pmid:26897386
Sbidian E et al. A Randomized-Controlled Trial of Oral Low-Dose Isotretinoin for Difficult-To-Treat Papulopustular Rosacea. 2016 J. Invest. Dermatol. pmid:26854486
Siebert N et al. Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2. 2016 MAbs pmid:26785755
Gorton HC et al. Non-psychotropic medication and risk of suicide or attempted suicide: a systematic review. 2016 BMJ Open pmid:26769782
Kushner BH et al. Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin. 2016 Oncotarget pmid:26623730
Ornelas J et al. Objective assessment of isotretinoin-associated cheilitis: Isotretinoin Cheilitis Grading Scale. 2016 J Dermatolog Treat pmid:26395167
Gupta D et al. Keratosis follicularis spinulosa decalvans showing excellent response to isotretinoin. 2015 Nov-Dec Indian J Dermatol Venereol Leprol pmid:26515859
Tagliolatto S et al. Sebaceous hyperplasia: systemic treatment with isotretinoin. 2015 Mar-Apr An Bras Dermatol pmid:25830991
Kraemer KH and DiGiovanna JJ Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. 2015 Mar-Apr Photochem. Photobiol. pmid:25220021
Bravo BS et al. Oral isotretinoin in photoaging: objective histological evidence of efficacy and durability. 2015 Jul-Aug An Bras Dermatol pmid:26375216
Hur J et al. Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. 2015 Chem. Res. Toxicol. pmid:25811541
Mora J et al. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). 2015 Clin Transl Oncol pmid:25596034
Singh A et al. Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells. 2015 J. Exp. Clin. Cancer Res. pmid:26384788
Milanovic D et al. Inhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivo. 2015 Oncotarget pmid:26362268
Kamal M and Polat M Effect of different doses of isotretinoin treatment on the levels of serum homocysteine, vitamin B 12 and folic acid in patients with acne vulgaris: A prospective controlled study. 2015 J Pak Med Assoc pmid:26338739
Rashtak S et al. Isotretinoin Exposure and Risk of Celiac Disease. 2015 PLoS ONE pmid:26287738
Sato Y et al. Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy. 2015 Medicine (Baltimore) pmid:26252303
Zhao S and Goodson NJ Diffuse idiopathic skeletal hyperostosis and isotretinoin in cystic acne. 2015 BMJ Case Rep pmid:26106176
Guzmán-Sánchez D and Asz-Sigall D Alopecias due to drugs and other skin and systemic disorders. 2015 Curr. Probl. Dermatol. pmid:26370648
Cantarutti N et al. Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin. 2015 Ital J Pediatr pmid:25881033
Karadag AS et al. The effect of different doses of isotretinoin on pituitary hormones. 2015 Dermatology (Basel) pmid:25721216
Stieglitz E et al. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. 2015 Pediatr Blood Cancer pmid:25704135
Güler E et al. An unknown side effect of isotretinoin: pericardial effusion with atrial tachycardia. 2015 Anatol J Cardiol pmid:25625453
Karadag AS et al. The effect of isotretinoin on retinol-binding protein 4, leptin, adiponectin and insulin resistance in acne vulgaris patients. 2015 Dermatology (Basel) pmid:25573071
Iwamoto FM and Lassman AB Factorial clinical trials: a new approach to phase II neuro-oncology studies. 2015 Neuro-oncology pmid:25452393
Krishna S et al. Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. 2015 JAMA Dermatol pmid:25251777
Penas-Prado M et al. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. 2015 Neuro-oncology pmid:25239666
Ratajewski M et al. Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. 2015 Toxicol. Lett. pmid:25455453
Su YS and Chang CH SAPHO syndrome associated with acne conglobata successfully treated with etanercept. 2015 J. Formos. Med. Assoc. pmid:24189486
Taylor SL et al. Palmoplantar papules and hyperkeratosis in a deaf man. 2014 Mar-Apr Skinmed pmid:24933850
Ucak H et al. Effect of oral isotretinoin treatment on retinal nerve fiber layer thickness. 2014 Jul-Aug J Cutan Med Surg pmid:25008440
Grando LR et al. Pseudo-acne fulminans associated with oral isotretinoin. 2014 Jul-Aug An Bras Dermatol pmid:25054758
Rouzès A and Jonville-Béra AP [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up]. 2014 Jan-Feb Therapie pmid:24698189
Mutizwa MM and Berk DR Dichotomous long-term response to isotretinoin in two patients with fordyce spots. 2014 Jan-Feb Pediatr Dermatol pmid:22486258
Mobacken H et al. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects]. 2014 Jan 15-28 Lakartidningen pmid:24552013
Kameoka S et al. A high-throughput screen for teratogens using human pluripotent stem cells. 2014 Toxicol. Sci. pmid:24154490
Bagatin E et al. Low-dose oral isotretinoin versus topical retinoic acid for photoaging: a randomized, comparative study. 2014 Int. J. Dermatol. pmid:24168514
Yoon JH et al. Concomitant use of an infrared fractional laser with low-dose isotretinoin for the treatment of acne and acne scars. 2014 J Dermatolog Treat pmid:23336106
Cetinözman F et al. Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne. 2014 J Dermatolog Treat pmid:23163983
Kaplan R et al. A case of isotretinoin-induced purpura annularis telangiectodes of Majocchi and review of substance-induced pigmented purpuric dermatosis. 2014 JAMA Dermatol pmid:24284887
Pinto N et al. Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation. 2014 Pediatr Blood Cancer pmid:24293072
Sikar Aktürk A et al. The effects of isotretinoin on the ovarian reserve of females with acne. 2014 Gynecol. Endocrinol. pmid:24256373
Pariente A [Isotretinoin does not increase the risk of intestinal inflammatory disease]. 2014 Rev Prat pmid:25090755
Peleg H et al. Radiologic features of acne fulminans. 2014 Isr. Med. Assoc. J. pmid:25059007
Racine A et al. Isotretinoin and risk of inflammatory bowel disease: a French nationwide study. 2014 Am. J. Gastroenterol. pmid:24535094
Giavedoni P et al. Acne fulminans successfully treated with cyclosporine and isotretinoin. 2014 J. Am. Acad. Dermatol. pmid:24438977
Cheung NK et al. Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma. 2014 Int. J. Cancer pmid:24644014
Pillai RN et al. Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501). 2014 Cancer Chemother. Pharmacol. pmid:24858462
Tan J et al. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin. 2014 Br. J. Dermatol. pmid:24934963
Duffy EK et al. Spurious elevation of aspartate aminotransferase in a patient on isotretinoin. 2014 J. Am. Acad. Dermatol. pmid:25219729
Dai C et al. Isotretinoin and risk of inflammatory bowel disease. 2014 Am. J. Gastroenterol. pmid:25196874
Racine A et al. Response to Dai et al. 2014 Am. J. Gastroenterol. pmid:25196875
Wootton CI et al. Should isotretinoin be stopped prior to surgery? A critically appraised topic. 2014 Br. J. Dermatol. pmid:24547720
Maschan M et al. Control of thrombotic thrombocytopenic purpura by sirolimus in a child with juvenile myelomonocytic leukemia and somatic N-RAS mutation. 2014 Pediatr Blood Cancer pmid:24590757
Chang LM and Reyes M A case of harlequin ichthyosis treated with isotretinoin. 2014 Dermatol. Online J. pmid:24612573
Chen SE et al. Isotretinoin maintenance therapy for glioblastoma: a retrospective review. 2014 J Oncol Pharm Pract pmid:23676507
Marrouche N et al. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. 2014 Int. J. Dermatol. pmid:24783259
Sardana K and Garg VK Antibiotic resistance in acne: is it time to look beyond antibiotics and Propionobacterium acnes? 2014 Int. J. Dermatol. pmid:24738843
Lebwohl B et al. Isotretinoin use and celiac disease: a population-based cross-sectional study. 2014 Am J Clin Dermatol pmid:25022269
Shah N et al. PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma. 2014 Clin. Cancer Res. pmid:24947929
D'souza P et al. Porokeratosis ptychotropica: a rare variant of porokeratosis. 2014 Dermatol. Online J. pmid:24945649
Barnes LE et al. Common reasons why acne patients call the office. 2014 Dermatol. Online J. pmid:24852769
Bendezú-García RÁ et al. Ulcerative colitis and isotretinoin: Is there a causal relationship? 2014 Rev Esp Enferm Dig pmid:24852746
Gollnick HP and Zouboulis CC Not all acne is acne vulgaris. 2014 Dtsch Arztebl Int pmid:24828100
Lamb RC et al. Avascular necrosis of the hip and diffuse idiopathic skeletal hyperostosis during long-term isotretinoin treatment of epidermolytic ichthyosis due to a novel deletion mutation in KRT10. 2014 Br. J. Dermatol. pmid:24720725
Tauber M et al. Unresectable perineal cuniculatum carcinoma: partial remission using systemic isotretinoin and interferon-α2a therapy. 2014 Acta Derm. Venereol. pmid:24676771
Fernández-Crehuet P et al. Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study. 2014 BMJ Open pmid:24650805
Lagan BM et al. Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies. 2014 Pharmacoepidemiol Drug Saf pmid:24493556
Noh S et al. A case of sebaceous hyperplasia maintained on low-dose isotretinoin after carbon dioxide laser treatment. 2014 Int. J. Dermatol. pmid:23621277
Aguilar S et al. Congenital neuroblastoma in a neonate with isotretinoin embryopathy. 2014 J. Pediatr. Hematol. Oncol. pmid:23652876